On Feb. 18, 2020, Sanofi announced it had leveraged previous development work for a SARS vaccine which may unlock a fast path forward for developing a COVID-19 vaccine.

Sanofi collaborated with the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Dept. of Health and Human Services.